This meta-analysis revealed that high expression of KIF2A and KIF20A was significantly correlated with poor OS and adverse clinicopathological features of patients with different types of cancer, indicating that these 2 KIF members can serve as unfavorable prognostic factors and novel therapeutic targets for human cancers. The gene discussed is KIF2A; the disease is cancer.